NASDAQ:NDRA - ENDRA Life Sciences Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.85
▼ -0.11 (-5.61%)

This chart shows the closing price for NDRA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ENDRA Life Sciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NDRA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NDRA

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for ENDRA Life Sciences in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $1.85.

This chart shows the closing price for NDRA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in ENDRA Life Sciences. This rating has held steady since October 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/18/2019HC WainwrightReiterated RatingBuy$6.00High
7/15/2019HC WainwrightInitiated CoverageBuy$6.00Low
6/13/2019Dougherty & CoInitiated CoverageBuyHigh
5/20/2019Lake Street CapitalInitiated CoverageBuyHigh
(Data available from 7/23/2016 forward)
ENDRA Life Sciences logo
ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. It develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. The company also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Read More

Today's Range

Now: $1.85
Low: $1.82
High: $1.95

50 Day Range

MA: $2.10
Low: $1.74
High: $2.37

52 Week Range

Now: $1.85
Low: $0.65
High: $3.10

Volume

322,474 shs

Average Volume

1,869,392 shs

Market Capitalization

$77.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Frequently Asked Questions

What sell-side analysts currently cover shares of ENDRA Life Sciences?

The following equities research analysts have issued research reports on ENDRA Life Sciences in the last year: Zacks Investment Research.
View the latest analyst ratings for NDRA.

What is the current price target for ENDRA Life Sciences?

0 Wall Street analysts have set twelve-month price targets for ENDRA Life Sciences in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for ENDRA Life Sciences in the next year.
View the latest price targets for NDRA.

What is the current consensus analyst rating for ENDRA Life Sciences?

ENDRA Life Sciences currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for NDRA.

What other companies compete with ENDRA Life Sciences?

How do I contact ENDRA Life Sciences' investor relations team?

ENDRA Life Sciences' physical mailing address is 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105. The company's listed phone number is 734-335-0468 and its investor relations email address is [email protected] The official website for ENDRA Life Sciences is www.endrainc.com.